Discover 134 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 134
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Chattanooga TN, Atlanta GA, Norcross GA,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase3, Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
for
Acute Ischemic Stroke
Location: Chattanooga TN, Columbus OH, St Louis MO, Toledo OH,
Sponsor: Corxel Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06990867
Phase2, Phase3, Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis
for
Arteriovenous Fistula Occlusion
Location: Chattanooga TN
Sponsor: Southeast Renal Research Institute
Sex: All
Age: 18 - 70+
Code: NCT03106948
Phase2, Recruiting
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
for
Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion,
Location: Chattanooga TN, Columbus GA, Charlotte NC,
Sponsor: Kuros Biosurgery AG
Sex: All
Age: 18 - 70+
Code: NCT07225751
Recruiting
Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
for
Postoperative Retention of Urine,
Location: Chattanooga TN
Sponsor: Memorial Health System
Sex: All
Age: 18+
Code: NCT01309529
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Chattanooga TN, Atlanta GA, Nashville TN, Athens GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Chattanooga TN, Huntsville AL, Knoxville TN, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer